ADT 2142 American Renaissance Portfolio -- A Cyrus J. Lawrence LLC (CJL) Portfolio Series 2022-2 

$11.20
0
+$0.00+0%Past Week

Statistics

Day High
-
Day Low
-
52W High
11.2
52W Low
11.2
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
0
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Dec 2024
$11.20
Jun 2024
$0.07
Dec 2023
$0.08
Jun 2023
$0.08
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Show More
CEO

Listings

0 Comments

Share your thoughts

FAQs

What is ADT 2142 American Renaissance Portfolio -- A Cyrus J. Lawrence LLC (CJL) Portfolio Series 2022-2 stock price today?▼
The current price of ARPACX is $11.20 USD — it has increased by +0% in the past 24 hours. Watch ADT 2142 American Renaissance Portfolio -- A Cyrus J. Lawrence LLC (CJL) Portfolio Series 2022-2 stock price performance more closely on the chart.
What is ADT 2142 American Renaissance Portfolio -- A Cyrus J. Lawrence LLC (CJL) Portfolio Series 2022-2 stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange ADT 2142 American Renaissance Portfolio -- A Cyrus J. Lawrence LLC (CJL) Portfolio Series 2022-2 stocks are traded under the ticker ARPACX.
Does ADT 2142 American Renaissance Portfolio -- A Cyrus J. Lawrence LLC (CJL) Portfolio Series 2022-2 pay dividends?▼
Yes, ARPACX dividends are paid semi-annual. The last dividend per share was 11.2 . As of today, Dividend Yield (FWD)% is 0%.
In which sector is ADT 2142 American Renaissance Portfolio -- A Cyrus J. Lawrence LLC (CJL) Portfolio Series 2022-2 located?▼
ADT 2142 American Renaissance Portfolio -- A Cyrus J. Lawrence LLC (CJL) Portfolio Series 2022-2 operates in the Other sector.
When did ADT 2142 American Renaissance Portfolio -- A Cyrus J. Lawrence LLC (CJL) Portfolio Series 2022-2 complete a stock split?▼
ADT 2142 American Renaissance Portfolio -- A Cyrus J. Lawrence LLC (CJL) Portfolio Series 2022-2 has not had any recent stock splits.